Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Not Yet Recruiting NCT05655117

Application of Artificial Intelligence in Early Detection of Eye Complications in Diabetics

Conditions: Artificial Intelegence, Diabetic Retinopathy Associated With Type 2 Diabetes Mellitus, Macular Edema Due to Type 2 Diabetes Mellitus

Sex: All
Ages: 18 Years – 90 Years
Healthy volunteers: 1
Phase: NA
Enrollment: 440
Sponsor: The New Model of Care, Hail Health Cluster

Summary

The goal of this pragmatic trial is to test the benefit of using artificial intelligence-based eye screening i.e, a fundus camera device in the early detection of eye complications in diabetics. The main questions it aims to answer are:To what extent does the application of artificial intelligence-based eye care at primary care clinics work well in achieving early detection of eye complications such as macular oedema? To what extent does the application of artificial intelligence-based eye care at primary care clinics work well in achieving early detection of eye complications such as retinopathy? Participants will be asked to participate in the screening for eye complications at primary care centres, and a fundus camera will be used for screening.Researchers will compare the proportion of detected cases with early signs of eye complication among those using artificial intelligence-based eye screening i.e., fundus camera, to the proportion of detected cases among those using routine eye care clinics at the primary care centre.Early detection of eye complications in diabetics prevents the risk of blindness.

Eligibility Criteria

Inclusion Criteria:Diabetic patients aged 18-90Exclusion Criteria:Severely ill patient or patient with cancer

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05655117). StuddyBuddy aggregates publicly available trial information.